PAPER Wang L, Nuytemans K, Bademci G, Jauregui C, Martin ER, Scott WK, Vance JM, Zuchner S
SEARCH RESULTS
331209 RESULTS
PAPER Borowsky B, Warner J, Leavitt BR, Tabrizi SJ, Roos RA, Durr A, Becker C, Sampaio C, Tobin AJ, Schulman H
8OHdG is not a biomarker for Huntington disease state or progression.
Neurology. 2013 May 21;80(21):1934-41. PubMed: 23616162PAPER Paraíso AF, Mendes KL, Santos SH
Brain Activation of SIRT1: Role in Neuropathology.
Mol Neurobiol. 2013 Apr 25; PubMed: 23615921PAPER Hiltunen M, Haapasalo A, Soininen H
[New risk genes for Alzheimer's disease--biomarkers predicting the disease?].
Duodecim. 2013;129(6):583-8. PubMed: 23614223PAPER Polk AL
Before Alzheimer's….
J Gerontol Nurs. 2013 Jul;39(7):55-6. PubMed: 23614383PAPER Sörgjerd KM, Zako T, Sakono M, Stirling PC, Leroux MR, Saito T, Nilsson P, Sekimoto M, Saido TC, Maeda M
Human Prefoldin Inhibits Amyloid-β (Aβ) Fibrillation and Contributes to Formation of Nontoxic Aβ Aggregates.
Biochemistry. 2013 May 8; PubMed: 23614719PAPER Costanzo M, Zurzolo C
The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Biochem J. 2013 May 15;452(1):1-17. PubMed: 23614720PAPER De Caluwé J, Dupont G
The progression towards Alzheimer's disease described as a bistable switch arising from the positive loop between amyloids and Ca(2+).
J Theor Biol. 2013 Aug 21;331:12-8. PubMed: 23614875PAPER Lim D, Iyer A, Ronco V, Grolla AA, Canonico PL, Aronica E, Genazzani AA
Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB.
Glia. 2013 Jul;61(7):1134-45. PubMed: 23616440PAPER Liu Q, Xie X, Lukas RJ, St John PA, Wu J
A novel nicotinic mechanism underlies β-amyloid-induced neuronal hyperexcitation.
J Neurosci. 2013 Apr 24;33(17):7253-63. PubMed: 23616534PAPER Johnson AA, Sarthi J, Pirooznia SK, Reube W, Elefant F
Increasing Tip60 HAT levels rescues axonal transport defects and associated behavioral phenotypes in a Drosophila Alzheimer's disease model.
J Neurosci. 2013 Apr 24;33(17):7535-47. PubMed: 23616558PAPER Crump CJ, Johnson DS, Li YM
Development and Mechanism of γ-Secretase Modulators for Alzheimer's Disease.
Biochemistry. 2013 May 2; PubMed: 23614767PAPER Dorsey ER, George BP, Leff B, Willis AW
The coming crisis: obtaining care for the growing burden of neurodegenerative conditions.
Neurology. 2013 May 21;80(21):1989-96. PubMed: 23616157PAPER Pause BM, Zlomuzica A, Kinugawa K, Mariani J, Pietrowsky R, Dere E
Perspectives on episodic-like and episodic memory.
Front Behav Neurosci. 2013;7:33. PubMed: 23616754Mikko Hiltunen on Does Progranulin Play Both Sides in AD and FTD?
COMMENT Perry et al. have identified two patients with Alzheimer’s disease (AD) pathology who also have a mutation in the progranulin (GRN) gene. This is an extremely important finding, considering that the GRN mutations are known to cause the autosomal-dominant
Current Filters
No filters selected